StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
9
This month
1
This year
1
Publishing Date
2024 - 04 - 01
1
2023 - 11 - 13
1
2022 - 09 - 27
1
2021 - 12 - 13
1
2021 - 06 - 11
2
2021 - 05 - 13
1
2021 - 03 - 15
1
2021 - 02 - 12
1
Sector
Health technology
9
Tags
Agreement
1
Association
1
Biocanada
1
Biomarker
1
Biomarkers
2
Biotech
1
Biotech-bay
1
Biotech-beach
19
Biotechnology
5
Blood
4
Calendar of events
1
Ces
1
Cibmtr
2
Clinical-trials-phase-i
2
Clinical-trials-phase-ii
2
Commercialization
1
Conference
11
Control
1
Day
1
Disease
13
Drug
3
Earnings
1
Eq101
2
Eq102
1
Europe
2
Ev
1
Events
12
Financial
2
Financial results
3
Ford
1
Global
4
Grant
1
Il-15
2
Immunology
2
Iot
1
Ipo
1
Life science
2
Lupus
6
Medical
1
Meeting
4
N/a
23
Nasdaq
1
News
1
Offering
2
People
1
Phase 1
4
Phase 1b
3
Phase 2
1
Phase 2b
3
Positive
9
Presentation
16
Research
10
Results
8
Study
7
T-cell
5
Therapeutics
2
Therapy
2
Topline
2
Treatment
3
Year
2
Entities
Abbvie inc.
31
Adial pharmaceuticals, inc
10
Alnylam pharmaceuticals, inc.
19
Amgen inc.
14
Amplitude healthcare acquisition corp
9
Annovis bio, inc.
10
Aquestive therapeutics, inc.
18
Arrival
21
Astellas pharma inc
14
Astrazeneca plc
13
Beigene, ltd.
19
Beyondspring, inc.
11
Biogen inc.
13
Biontech se
17
Bridgebio pharma, inc.
16
Bristol-myers squibb company
27
Celldex therapeutics, inc.
10
Clearside biomedical, inc.
15
Coherus biosciences, inc.
21
Dare bioscience, inc.
13
Eli lilly and company
30
Equillium, inc.
9
Fortress biotech, inc.
10
Gartner, inc.
12
Gilead sciences, inc.
13
Glaxosmithkline plc
12
Halozyme therapeutics, inc.
9
Hoth therapeutics, inc.
14
I-mab
9
Immix biopharma, inc.
10
Immutep limited
11
Incyte corporation
15
Ionis pharmaceuticals, inc.
21
Johnson & johnson
46
Kering
11
Lithium corp
14
Mediwound ltd.
11
Merck & company, inc.
19
Morgan stanley
10
Myovant sciences ltd.
10
Nasdaq, inc.
42
Novartis ag
19
Orange
21
Pfizer, inc.
45
Pliant therapeutics, inc.
10
Redhill biopharma ltd.
10
Regeneron pharmaceuticals, inc.
26
Regenxbio inc.
17
Rocket pharmaceuticals, inc.
11
Sanofi
103
Scynexis, inc.
11
Sellas life sciences group, inc.
11
Sorrento therapeutics, inc.
19
Takeda pharmaceutical company limited
14
Taylor devices, inc.
17
Teva pharmaceutical industries ltd
14
Tonix pharmaceuticals holding corp.
12
Transcode therapeutics inc
10
Vertex pharmaceuticals incorporated
11
Veru inc.
10
Symbols
EQ
9
MTCR
1
SNY
1
Exchanges
Nasdaq
9
Crawled Date
2024 - 04 - 01
1
2023 - 11 - 13
1
2022 - 09 - 27
1
2021 - 12 - 13
1
2021 - 06 - 11
2
2021 - 05 - 13
1
2021 - 03 - 15
1
2021 - 02 - 12
1
Crawled Time
12:00
3
12:15
1
13:30
1
17:00
1
18:00
1
19:00
1
20:03
1
Source
www.biospace.com
6
www.globenewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Positive
entities :
Equillium, inc.
save search
Equillium Announces Positive Topline Data from the Type B Portion of the Phase 1b EQUALISE Study of Itolizumab in Lupus Nephritis
Published:
2024-04-01
(Crawled : 19:00)
- biospace.com/
EQ
|
$1.63
-5.78%
-6.13%
100K
|
Health Technology
|
-30.3%
|
O:
-1.73%
H:
0.0%
C:
-7.05%
lupus
positive
topline
study
Equillium Presents Positive Data from Phase 1b EQUALISE Study at the 2023 Annual Meeting of the American College of Rheumatology
Published:
2023-11-13
(Crawled : 17:00)
- biospace.com/
EQ
|
$1.63
-5.78%
-6.13%
100K
|
Health Technology
|
224.86%
|
O:
0.08%
H:
6.43%
C:
0.81%
positive
meeting
study
Equillium Announces Positive Interim Results from the EQUALISE Study in Subjects with Lupus Nephritis
Published:
2022-09-27
(Crawled : 12:00)
- biospace.com/
MTCR
|
$0.5814
-5.14%
84K
|
Health Technology
|
38.43%
|
O:
6.83%
H:
13.66%
C:
10.88%
EQ
|
$1.63
-5.78%
-6.13%
100K
|
Health Technology
|
-16.58%
|
O:
15.54%
H:
14.35%
C:
6.28%
lupus
positive
results
study
Equillium Announces Additional Patient Data at ASH 2021 Demonstrating Continued Positive and Durable Clinical Responses in Acute Graft-Versus-Host Disease Patients Treated with Itolizumab
Published:
2021-12-13
(Crawled : 13:30)
- biospace.com/
EQ
|
$1.63
-5.78%
-6.13%
100K
|
Health Technology
|
-66.18%
|
O:
-0.21%
H:
0.95%
C:
-2.11%
disease
positive
EHA Updates: Companies Share Positive Data in Different Blood Disorders
Published:
2021-06-11
(Crawled : 18:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-13.91%
|
O:
0.13%
H:
0.11%
C:
-0.09%
EQ
|
$1.63
-5.78%
-6.13%
100K
|
Health Technology
|
-76.93%
|
O:
-6.16%
H:
0.31%
C:
-6.41%
blood
positive
Equillium Announces Positive Topline Results from the EQUATE Study in First-line Treatment of Acute Graft-Versus-Host Disease
Published:
2021-06-11
(Crawled : 12:00)
- biospace.com/
EQ
|
$1.63
-5.78%
-6.13%
100K
|
Health Technology
|
-76.93%
|
O:
-6.16%
H:
0.31%
C:
-6.41%
disease
treatment
positive
results
topline
Equillium Announces Oral Presentation Highlighting Positive Data from the EQUATE Study in Acute Graft-Versus-Host Disease at the EHA2021 Virtual Congress of the European Hematology Association
Published:
2021-05-13
(Crawled : 12:15)
- globenewswire.com
EQ
|
$1.63
-5.78%
-6.13%
100K
|
Health Technology
|
-68.49%
|
O:
3.72%
H:
5.28%
C:
-0.94%
presentation
disease
europe
positive
Equillium Announces Positive Data for Itolizumab in Acute Graft-Versus-Host Disease in Two Presentations at the 47th Annual Meeting of the European Society for Blood and Marrow Transplantation
Published:
2021-03-15
(Crawled : 12:00)
- globenewswire.com
EQ
|
$1.63
-5.78%
-6.13%
100K
|
Health Technology
|
-79.65%
|
O:
3.03%
H:
6.75%
C:
1.84%
presentation
disease
blood
positive
Equillium Presents Positive Interim Clinical Data of Itolizumab in First-line Treatment of Acute Graft-Versus-Host Disease at the 2021 Transplantation and Cellular Therapy Meetings Digital Experience
Published:
2021-02-12
(Crawled : 20:03)
- globenewswire.com
EQ
|
$1.63
-5.78%
-6.13%
100K
|
Health Technology
|
Email alert
Add to watchlist
disease
treatment
positive
therapy
Gainers vs Losers
67%
33%
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.